Jang Ming-kuei
entrepreneurMale0.0Global Dominance: 0.00%
Jang Ming-kuei is the founder of Aprinoia, a transnational biotech company focused on developing innovative diagnostic tools for Alzheimer's disease. His work includes the development of a tau protein imaging agent that aims to visualize tau accumulation in the brain, which is crucial for early detection and treatment planning for Alzheimer's patients.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Jang Ming-Kuei, founder and chairman of Aprinoia Therapeutics, presented findings on the diagnostic performance of tau PET imaging.
FMPAT tout better way to test dementiaTaipei Times – major English newspaper in Taiwan, est. 1999·
Taiwan· 2025-12-01
Taiwan· 2025-12-01
Jang Ming-kuei, founder of the biotech company Aprinoia, discussed a tau protein imaging agent developed by his company.
Better Alzheimer’s diagnostic tools needed: expertsTaipei Times – major English newspaper in Taiwan, est. 1999·Taiwan· 2025-06-28
Taiwan· 2025-06-28
